Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BNIP3 pseudogene 45 is a non-coding genomic locus annotated as a pseudogene of the BCL2 interacting protein 3 (BNIP3) gene. It is cataloged as gene ID 127379725 in NCBI Gene and ENSG00000271146 in Ensembl. Pseudogenes are typically regarded as non-functional remnants of protein-coding genes and do not encode functional proteins. There is no evidence that BNIP3P45 produces an active protein, participates in signaling, or has a role in disease pathophysiology or as a therapeutic target. All known biological and disease functions, as well as drug interactions relevant to the BNIP3 family, refer to the bona fide protein-coding BNIP3 gene, not this pseudogene[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BNIP3 pseudogene 45 (BNIP3P45).